ID: 263 Loss of IL-6/Stat3 signalling drives metastatic prostate cancer in mice and men

Jan Pencik, Michaela Schlederer, Wolfgang Gruber, Christine Unger, Steven Walker, Athena Chalaris, I Marie, Melanie R Hassler, Tahereh Javaheri, O Aksov, Jaine Blayney, P Mazal, F Grebien, G Egger, V Poli, R Eferl, Richard Kennedy, Falko Fend, Marcus Scharpf, M. BraunSven Perner, David E Levy, Tim Malcolm, SD Turner, A Haitel, M Susani, A Moazzami, S Rose-John, F Aberger, O Merkel, R Morrigi, Z Culig, H Dolznig, Lukas Kenner

Research output: Contribution to journalMeeting abstract

Original languageEnglish
Pages (from-to)112
Number of pages1
JournalCytokine
Volume76
Issue number1
Early online date11 Sep 2015
DOIs
Publication statusPublished - Nov 2015

Cite this

Pencik, J., Schlederer, M., Gruber, W., Unger, C., Walker, S., Chalaris, A., Marie, I., Hassler, M. R., Javaheri, T., Aksov, O., Blayney, J., Mazal, P., Grebien, F., Egger, G., Poli, V., Eferl, R., Kennedy, R., Fend, F., Scharpf, M., ... Kenner, L. (2015). ID: 263 Loss of IL-6/Stat3 signalling drives metastatic prostate cancer in mice and men. Cytokine, 76(1), 112. https://doi.org/10.1016/j.cyto.2015.08.257